Jason White, Pharm.D.
Kirkland,WA
Summary
Accomplished medical affairs professional with over 20 years of industry experience in Oncology, including 6 years as a RMSD/MSL at Merck. Trusted and respected leader within the ONE GU team, with a deep passion for mentoring and developing colleagues. Proven ability to plan and execute on field work and handle high-profile projects and assignments. Seeking to leverage key strengths for a transition into a field medical team lead role.
Overview
21
21
years of professional experience
Work History
Regional Medical Scientific Director (GU Oncology)
Merck (US Medical Affairs)
08.2020 - Current
- Territory: Pacific NW (WA/OR/AK/ID/MT/WY)
- Supported GU Oncology portfolio, external collaborations and pipeline compounds
- Core activities included scientific support for clinical trials and MISP/OTSP protocols and engaging in robust scientific exchange related to Merck and competitor data for RCC, Prostate and Bladder (UC/MIBC/NMIBC) cancers
- Completed inaugural cohort of Merck Aspiring Managers Program through FM CoE (2023-24)
- Presented AMP Capstone project (Leadership Case Study Learning Resource) at USMA Managers Meeting (2024)
- Selected as ONE GU Team MVP for 2023 (peer-nominated award)
- Tumor Lead for RCC clinical program (2022-present)
- Protocol Lead for LITESPARK-012 (1L RCC triplets, largest RCC trial ever conducted)
- Onboarding Partner/Mentor for 3 new GU team colleagues
- Co-led RCC new hire verbalizations with SDMA (trained 8 new GU team colleagues)
- USMA Co-Lead for ESMO 2022
- Led Scientific Session for Lung team in 2022 ("Pembro/lenva combinations from the GU perspective")
- Led Scientific Session for ONE GU team in 2021 ("Differentiation of TKIs used in RCC")
- Selected to contribute multiple voice from the field recordings for various USMA meetings
Medical Science Liaison (Oncology)
Blueprint Medicines
01.2020 - 08.2020
- Territory: Pacific NW (WA/OR/N. CA/AK/ID/MT)
- Supported oncology portfolio and pipeline compounds, including: avapritinib, BLU-667 (pralsetinib)
- Core activities included scientific support for early and late-stage clinical trials and engaging in robust scientific exchange around Blueprint and competitor data related to GIST, AdvSM/ISM, NSCLC (RET or EGFR+) and Thyroid cancer
- Global Training Lead for avapritinib GIST clinical program
- MSL Field Insights Committee (GIST insights lead)
- Published bi-weekly pralsetinib Literature Alert report
- Edited existing avapritinib Med Info SRLs
Regional Medical Scientific Director (GI Oncology)
Merck (US Medical Affairs)
03.2019 - 01.2020
- Territory: Pacific NW/Upper Midwest (WA/OR/AK/ID/MT/ND/SD/MN)
- Supported GI Oncology portfolio, external collaborations and pipeline compounds
- Core activities included scientific support for clinical trials and MISP/OTSP protocols and engaging in robust scientific exchange related to Merck and competitor data for RCC, Prostate and Bladder (UC/MIBC/NMIBC) cancers
- Core activities included scientific support for clinical trials and MISP/OTSP protocols and engaging in robust scientific exchange related to Merck and competitor data for HCC, Biliary, CRC, Gastric, Esophageal and Pancreatic cancers
- Tumor Lead for Hepatobiliary (HBC) clinical program (2019)
- Protocol Lead for LEAP-012 (intermediate-stage HCC) and KN-240 (2L HCC)
- Co-led planning efforts for HCC Clinical Immersion (2019)
- Co-led monthly cross-functional HBC Tumor Council meetings
- Contributed to GSC work stream that developed Merck Congress Portal
Director, Medical Science Liaison (Oncology - GI/GU/Melanoma)
Merck (Oncology Global Medical Affairs)
10.2017 - 03.2019
- Territory: Pacific NW (WA/OR/AK/ID/MT/ND/SD)
- Core activities included engaging in robust scientific exchange and serving as field-based medical information resource for Merck and competitor data related to GI/GU cancers and Melanoma
- SME for RCC and HCC
- Coordinated with CTD/MASL teams with development of training curriculum for RCC/HCC and facilitated verbalization review sessions for MSL team
- Provided onboarding guidance and mentored multiple new MSL colleagues
- MSL field mentor for PharmD fellows and P4 APPE students
- Led development of MSL congress summary template
Associate Director, Medical Science Liaison (Oncology/Immunology)
Novartis, Sandoz Division (US Medical Affairs)
07.2015 - 09.2017
- Territory: Pacific NW (WA/OR/AK/N. CA/ID/MT/UT/NV)
- Supported oncology/immunology biosimilar portfolio and pipeline compounds, including: filgrastim-sndz, etanercept-szzs, LA-EP2006 (pegfilgrastim), GP2013 (rituximab), GP2019 (bevacizumab), GP2017 (adalimumab)
- Core activities included engaging in robust scientific exchange, serving as field-based medical information resource for Sandoz and competitor data, supporting investigator-initiated study program and providing HEOR/RWE outreach support
- MSL Asset Lead for GP2013/rituximab (2016-17)
- Led planning and execution for two Medical Advisory Boards (HOPA, Oncology NP/PA)
- Led development of Biosimilar Pipeline brochure and slide deck (reactive MSL resource)
- Led weekly Hematology clinical training sessions
- MSL Lead for SABCS 2016
Oncology Account Specialist
Pfizer (Oncology Division)
01.2004 - 01.2013
- Territory: Western WA/AK
- Cultivated and maintained strong relationships with academic KOLs specializing in GI, GU and Breast cancers as well as community oncologists
- Facilitated multiple visits from Pfizer HQ or Medical Affairs to meet with KOLs at UW/SCCA
- Completed two-day GU Oncology preceptorship at MD Anderson Cancer Center
- Served as a national trainer and clinical training mentor for new representatives in the oncology division
- Participated in three new product launches (SUTENT, INLYTA, AROMASIN) and multiple new indications
- 4-time Seattle District Representative of the Year (2005, 2009, 2010, 2011)
Education
Doctor of Pharmacy (Pharm.D.) -
Creighton University
Omaha, NEB.S. in Biology, Minor in Chemistry -
Western Washington University
Bellingham, WASkills
- Leadership Training Experience
- Teamwork and Collaboration
- Mentoring and Coaching
- Relationship Building
- Training and Development
- Scientific Communication
- Strategic Planning
- Project Planning and Execution
- Meeting Facilitation
- Adaptability and Flexibility
- Motivational Skills
- Positive Attitude
Leadershipvolunteeractivities
- Volunteer Manager/Head Coach for youth girls softball - Kirkland American Little League
- Water Volunteer for Team Merck during Swim Across America event - September 2018/2019 - Seattle Open Water Swim (Lake Washington)
- Rho Chi Pharmacy Student Tutor - PHA 337/447 (Chemical Basis of Drug Action I/II) and MIC 541 (Microbiology and Immunology)
- Student Mentor for 1st year to 3rd year distance pharmacy students - Creighton University SPAHP
Key Qualifications
- Medical affairs industry professional with 18 years of experience in the oncology therapeutic space and over 3 years in immunology (over 5 years as RMSD/MSL at Merck)
- Managed a large geography in the Pacific NW cultivating and maintaining strong relationships with oncology and immunology SLs/investigators with an emphasis on GU and GI cancers
- Collaborative team player with extensive background planning and executing on special projects/assignments
- Proven leader with significant experience mentoring and training new MSL colleagues
- Participating in inaugural cohort of Merck USMA Leadership Development Program (2023)
Awards
- Dean's Honor Roll (awarded all 9 semesters of Pharm.D. curriculum) - Creighton University SPAHP
- Rho Chi Pharmacy Honor Society (Alpha Alpha Chapter) - Inducted in 2012 - Creighton University SPAHP
- Premier Performance Award (Pfizer's highest sales honor) - Pfizer, Inc. (Steere Division, Oncology Division)
Leadership and Volunteer Activities
Volunteer Coach - Elevate NW Premier 16U softball team (2023-24)
Volunteer Coach - Merchants 14U softball team (2021-23)
Volunteer Head Coach - Kirkland American Little League softball team (2013-21)
Water Volunteer for Team Merck - Swim Across America (2018-19)
Rho Chi Pharmacy Student Tutor - Creighton University (2013-15)
Timeline
Regional Medical Scientific Director (GU Oncology)
Merck (US Medical Affairs)
08.2020 - Current
Medical Science Liaison (Oncology)
Blueprint Medicines
01.2020 - 08.2020
Regional Medical Scientific Director (GI Oncology)
Merck (US Medical Affairs)
03.2019 - 01.2020
Director, Medical Science Liaison (Oncology - GI/GU/Melanoma)
Merck (Oncology Global Medical Affairs)
10.2017 - 03.2019
Associate Director, Medical Science Liaison (Oncology/Immunology)
Novartis, Sandoz Division (US Medical Affairs)
07.2015 - 09.2017
Oncology Account Specialist
Pfizer (Oncology Division)
01.2004 - 01.2013
Doctor of Pharmacy (Pharm.D.) -
Creighton University
B.S. in Biology, Minor in Chemistry -
Western Washington University
Similar Profiles
Avery PruittAvery Pruitt
Operations Technician at MerckOperations Technician at Merck
Reginald Henderson IIReginald Henderson II
E- Discovery Analyst at MerckE- Discovery Analyst at Merck
Antoine GillmannAntoine Gillmann
Formulation Expert at MerckFormulation Expert at Merck